242 related articles for article (PubMed ID: 27191989)
21. Proteomic analysis reveals overexpression of moesin and cytokeratin 17 proteins in colorectal carcinoma.
Kim CY; Jung WY; Lee HJ; Kim HK; Kim A; Shin BK
Oncol Rep; 2012 Mar; 27(3):608-20. PubMed ID: 22076435
[TBL] [Abstract][Full Text] [Related]
22. Far from resolved: stromal cell-based iTRAQ research of muscle-invasive bladder cancer regarding heterogeneity.
Liu PF; Wang YH; Cao YW; Jiang HP; Yang XC; Wang XS; Niu HT
Oncol Rep; 2014 Oct; 32(4):1489-96. PubMed ID: 25050759
[TBL] [Abstract][Full Text] [Related]
23. Quantitative proteomic analysis of differential proteins in the stroma of nasopharyngeal carcinoma and normal nasopharyngeal epithelial tissue.
Li MX; Xiao ZQ; Liu YF; Chen YH; Li C; Zhang PF; Li MY; Li F; Peng F; Duan CJ; Yi H; Yao HX; Chen ZC
J Cell Biochem; 2009 Mar; 106(4):570-9. PubMed ID: 19142861
[TBL] [Abstract][Full Text] [Related]
24. Comparative serum proteome analysis of human lymph node negative/positive invasive ductal carcinoma of the breast and benign breast disease controls via label-free semiquantitative shotgun technology.
Hu X; Zhang Y; Zhang A; Li Y; Zhu Z; Shao Z; Zeng R; Xu LX
OMICS; 2009 Aug; 13(4):291-300. PubMed ID: 19624269
[TBL] [Abstract][Full Text] [Related]
25. Stroma derived COL6A3 is a potential prognosis marker of colorectal carcinoma revealed by quantitative proteomics.
Qiao J; Fang CY; Chen SX; Wang XQ; Cui SJ; Liu XH; Jiang YH; Wang J; Zhang Y; Yang PY; Liu F
Oncotarget; 2015 Oct; 6(30):29929-46. PubMed ID: 26338966
[TBL] [Abstract][Full Text] [Related]
26. Identification of aldolase A as a potential diagnostic biomarker for colorectal cancer based on proteomic analysis using formalin-fixed paraffin-embedded tissue.
Yamamoto T; Kudo M; Peng WX; Takata H; Takakura H; Teduka K; Fujii T; Mitamura K; Taga A; Uchida E; Naito Z
Tumour Biol; 2016 Oct; 37(10):13595-13606. PubMed ID: 27468721
[TBL] [Abstract][Full Text] [Related]
27. Tenascin-W, a new marker of cancer stroma, is elevated in sera of colon and breast cancer patients.
Degen M; Brellier F; Schenk S; Driscoll R; Zaman K; Stupp R; Tornillo L; Terracciano L; Chiquet-Ehrismann R; Rüegg C; Seelentag W
Int J Cancer; 2008 Jun; 122(11):2454-61. PubMed ID: 18306355
[TBL] [Abstract][Full Text] [Related]
28. Periostin expression in intra-tumoral stromal cells is prognostic and predictive for colorectal carcinoma via creating a cancer-supportive niche.
Xu X; Chang W; Yuan J; Han X; Tan X; Ding Y; Luo Y; Cai H; Liu Y; Gao X; Liu Q; Yu Y; Du Y; Wang H; Ma L; Wang J; Chen K; Ding Y; Fu C; Cao G
Oncotarget; 2016 Jan; 7(1):798-813. PubMed ID: 26556874
[TBL] [Abstract][Full Text] [Related]
29. Smad4 loss is associated with fewer S100A8-positive monocytes in colorectal tumors and attenuated response to S100A8 in colorectal and pancreatic cancer cells.
Ang CW; Nedjadi T; Sheikh AA; Tweedle EM; Tonack S; Honap S; Jenkins RE; Park BK; Schwarte-Waldhoff I; Khattak I; Azadeh B; Dodson A; Kalirai H; Neoptolemos JP; Rooney PS; Costello E
Carcinogenesis; 2010 Sep; 31(9):1541-51. PubMed ID: 20622003
[TBL] [Abstract][Full Text] [Related]
30. Biomarker discovery in low-grade breast cancer using isobaric stable isotope tags and two-dimensional liquid chromatography-tandem mass spectrometry (iTRAQ-2DLC-MS/MS) based quantitative proteomic analysis.
Bouchal P; Roumeliotis T; Hrstka R; Nenutil R; Vojtesek B; Garbis SD
J Proteome Res; 2009 Jan; 8(1):362-73. PubMed ID: 19053527
[TBL] [Abstract][Full Text] [Related]
31. Cancer-associated stroma reveals prognostic biomarkers and novel insights into the tumour microenvironment of colorectal cancer and colorectal liver metastases.
Brown KM; Xue A; Smith RC; Samra JS; Gill AJ; Hugh TJ
Cancer Med; 2022 Jan; 11(2):492-506. PubMed ID: 34874125
[TBL] [Abstract][Full Text] [Related]
32. Identification and Verification of Two Novel Differentially Expressed Proteins from Non-neoplastic Mucosa and Colorectal Carcinoma Via iTRAQ Combined with Liquid Chromatography-Mass Spectrometry.
Bai Y; Wang J; Gao Z; Dai E
Pathol Oncol Res; 2020 Apr; 26(2):967-976. PubMed ID: 30927204
[TBL] [Abstract][Full Text] [Related]
33. Tenascin-C is a potential cancer-associated fibroblasts marker and predicts poor prognosis in prostate cancer.
Ni WD; Yang ZT; Cui CA; Cui Y; Fang LY; Xuan YH
Biochem Biophys Res Commun; 2017 May; 486(3):607-612. PubMed ID: 28341124
[TBL] [Abstract][Full Text] [Related]
34. Proteomic Characterization of Colorectal Cancer Cells versus Normal-Derived Colon Mucosa Cells: Approaching Identification of Novel Diagnostic Protein Biomarkers in Colorectal Cancer.
Ludvigsen M; Thorlacius-Ussing L; Vorum H; Moyer MP; Stender MT; Thorlacius-Ussing O; Honoré B
Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32422974
[TBL] [Abstract][Full Text] [Related]
35. High Co-expression of Large Tenascin C Splice Variants in Stromal Tissue and Annexin A2 in Cancer Cell Membranes is Associated with Poor Prognosis in Pancreatic Cancer.
Hagiwara K; Harimoto N; Yokobori T; Muranushi R; Hoshino K; Gantumur D; Yamanaka T; Ishii N; Tsukagoshi M; Igarashi T; Tanaka H; Watanabe A; Kubo N; Araki K; Hosouchi Y; Shirabe K
Ann Surg Oncol; 2020 Mar; 27(3):924-930. PubMed ID: 31463696
[TBL] [Abstract][Full Text] [Related]
36. Positive feedback loop of hepatoma-derived growth factor and β-catenin promotes carcinogenesis of colorectal cancer.
Lian J; Tang J; Shi H; Li H; Zhen T; Xie W; Zhang F; Yang Y; Han A
Oncotarget; 2015 Oct; 6(30):29357-74. PubMed ID: 26296979
[TBL] [Abstract][Full Text] [Related]
37. Stromal TRIM28-associated signaling pathway modulation within the colorectal cancer microenvironment.
Fitzgerald S; Espina V; Liotta L; Sheehan KM; O'Grady A; Cummins R; O'Kennedy R; Kay EW; Kijanka GS
J Transl Med; 2018 Apr; 16(1):89. PubMed ID: 29631612
[TBL] [Abstract][Full Text] [Related]
38. Identification of differentially-expressed proteins between early submucosal non-invasive and invasive colorectal cancer using 2D-DIGE and mass spectrometry.
Zhang J; Song MQ; Zhu JS; Zhou Z; Xu ZP; Chen WX; Chen NW
Int J Immunopathol Pharmacol; 2011; 24(4):849-59. PubMed ID: 22230392
[TBL] [Abstract][Full Text] [Related]
39. The role of Tenascin-C and Twist1 in gastric cancer: cancer progression and prognosis.
Qi W; Yang Z; Li H; Cui Y; Xuan Y
APMIS; 2019 Feb; 127(2):64-71. PubMed ID: 30698309
[TBL] [Abstract][Full Text] [Related]
40. DDX3 as a strongest prognosis marker and its downregulation promotes metastasis in colorectal cancer.
Su CY; Lin TC; Lin YF; Chen MH; Lee CH; Wang HY; Lee YC; Liu YP; Chen CL; Hsiao M
Oncotarget; 2015 Jul; 6(21):18602-12. PubMed ID: 26087195
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]